Only twenty nine percent of Hispanics who rent their homes report having renters insurance, according to a new survey by State Farm. In fact, among respondents without renters insurance more than one third (34%) said they had never heard of renters insurance. Further, most overestimated the cost of coverage and underestimated the value of their property. Not having renters insurance could leave Hispanic families vulnerable to a financial catastrophe especially during the holiday season.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72928515-state-farm-hispanic-renters-survey/
An amazing story of a young man named Kenneth, who thought he was a saved Christian, until he had a Near Death Experience that forever changed his life.
There is a bankruptcy involving claims about exposure to asbestos-containing gaskets, packing, and equipment. Garlock Sealing Technologies LLC, The Anchor Packing Company, and Garrison Litigation Management Group, Ltd., along with representatives of asbestos claimants, have filed a new plan of reorganization (the “Plan”). Coltec Industries Inc is also part of the Plan. If claimants approve the Plan, Coltec will merge with a company known as OldCo, LLC, and that company will file a bankruptcy case. Together, these companies are referred to as the “Debtors.”
The gaskets and packing were used in places where steam, hot liquid, or acids moved through pipes, including industrial and maritime settings. The equipment included compressors, engines, pumps, transformers, and other equipment that may have had asbestos-containing components, such as gaskets or packing. The Coltec-related divisions or businesses that may have sold asbestos-containing products or equipment were Fairbanks Morse, Quincy Compressor, Central Moloney, Delavan, France Compressor, and Farnam.
To view the multimedia release go to:
http://www.multivu.com/players/English/7904751-garlock-coltec-asbestos-bankruptcy/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
https://tinyurl.com/y7x2j3na Tinnitus: Do You Want The Ringing in Your Ears to Stop?
Recently, my sister asked me if I knew of any natural remedy for ringing in the ears. She said the ringing was keeping her awake at night. And, her daughter has the same problem. Her daughter had to listen to a loud radio to mask the ringing so that she could concentrate on doing her job.
Volvo Cars, a leader in the field of connectivity in the automotive sector, is set to disrupt the delivery experience with the introduction a new service that promises In-car Delivery of your online shopping in under two hours.
The ground-breaking collaboration with Swedish start-up urb-it will enable Volvo Cars to expand its tried and tested In-car Delivery Service and provide a foundation for a game-changing approach to delivery services, while reimagining how we use our cars.
“We understand the value of the In-car Delivery service we have developed. We’ve all had phone calls at work from delivery people trying to deliver packages to our homes that need to be signed for when there is no one home. With our In-car Delivery service we effectively turn your car into a delivery location and assign a one-time digital key to the delivery person, effectively eliminating delivery failure,” said Björn Annwall, Senior Vice President Marketing Sales and Service at Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7832251-volvo-in-car-delivery-service/
..and we have a winner people! One of the best video reviews for Freebug.co.uk that we received.. the UKs first 100% cashback site!. I'll have what she's had please!
An exclusive Grand Opening was held the evening of May 28th, 2016 in the newly opened FURSAN luxury Flagship Boutique, located on La Croisette18, Parcel 10, Porto Arabia, the Pearl Qatar; a magnificent, luxurious retail environment dedicated to opulence and consummate beauty.
FURSAN, based in Qatar, is the brainchild of Ibrahim Al-Haidos, Founder & Creative Director of the brand and the FURSAN Collection of unrivalled luxury handbags, designed in celebration of the tradition of Dazzah.
Asked what motivated him to design such exquisite, sumptuous handbags, Ibrahim Al-Haidos replied, “I have always had a romantic relationship with commerce and entrepreneurship. Combining my interest in leather goods and fashion, I seek to put Qatar on the luxury fashion map and make it a major destination for luxury brands. I want to give customers the true experience of extravagance by treating them as honored guests when they enter our glorious boutique.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7910551-fursan-grand-opening-flagship-boutique/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
